Mezigdomide (CC-92480) 是一种有效的、新型的 、具有选择性的和具有活性的cereblon E3 泛素连接酶调节剂(CELMoD),常以分子胶的方式发挥作用。Mezigdomide 具有抗骨髓瘤活性。[1] 规格价格库存数量 1 mg ¥ 1,060 现货 5 mg ¥ 2,650 现货 10 mg ¥ 3,890 现货 25 mg ¥ 6,280 现货...
Mezigdomide (CC-92480) is a novel protein degrader and a cereblon E3 ligase modulator (CELMoD) that has anti-myeloma activity.
Mezigdomide (CC-92480), a Novel Cereblon E3 Ligase Modulator, Induces Vulnerability of Multiple Myeloma Cells to T-Cell-Mediated Killing 来自 dx.doi.org 喜欢 0 阅读量: 4 作者: B Gaffney,S Yu,PD Jong,M Sánchez,C Fontanillo,A Lopez-Girona,I Boss,A Kurtova,S Carrancio,L Wong 展开 ...
一项在复发或难治性多发性骨髓瘤(RRMM)受试者中比较Mezigdomide(CC-92480/BMS-986348)、卡非佐米和地塞米松(MeziKd)与卡非佐米和地塞米松(Kd)的III期、两阶段、随机、多中心、开放性研究:SUCCESSOR-2项目名称,国科人遗审字〔2024〕GH0187号审批号,遗传资源国际合作
Mezigdomide (Synonyms: CC-92480) 纯度: 98.02% Mezigdomide (CC-92480) 是一种 cereblon E3 泛素连接酶调节药物 (CELMoD),以分子胶的方式作用。Mezigdomide 与 cereblon 有较强的亲和力,具有抗骨髓瘤活性。 Mezigdomide Chemical Structure CAS No. : 2259648-80-9 规格价格是否有货数量 5 mg ￥35...
Paul Richardson, MD, discusses the background and design of the CC-92480-MM-002 trial in multiple myeloma.Video Player is loading.This is a modal window. This video is either unavailable or not supported in this browserError Code: MEDIA_ERR_SRC_NOT_SUPPORTEDTechnical details : No compatible...
Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Daratumumab (DARA) or Elotuzumab (ELO) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the CC-92480-MM-002 Trial 来自 dx.doi.org 喜欢 0 阅读量: 4 作者: PG Richardson,I Sandhu,CC Hofmeister,RZ Orlowski,D ...
Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from the CC-92480-MM-002 Trial 来自 dx.doi.org 喜欢 0 阅读量: 1 ...